Insider Transactions in Q1 2021 at Idera Pharmaceuticals, Inc. (IDRA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,495,809
+24.06%
|
$0
$0.01 P/Share
|
|
Mar 25
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,250
-18.45%
|
$6,250
$1.42 P/Share
|
|
Mar 25
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
7,630
-20.05%
|
$7,630
$1.36 P/Share
|
|
Mar 25
2021
|
Elizabeth Ann Tarka CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,018
-27.49%
|
$5,018
$1.35 P/Share
|
|
Mar 18
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
1,699,765
+20.89%
|
$1,699,765
$1.8 P/Share
|
|
Mar 05
2021
|
Daniel B Soland CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+25.74%
|
$30,000
$3.9 P/Share
|
|
Jan 20
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
643,525
+24.99%
|
$0
$0.01 P/Share
|
|
Jan 12
2021
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
3,210
-1.52%
|
$12,840
$4.2 P/Share
|
|
Jan 12
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
1,711
-4.3%
|
$6,844
$4.21 P/Share
|
|
Jan 12
2021
|
Elizabeth Ann Tarka CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,745
-8.73%
|
$6,980
$4.19 P/Share
|
|
Jan 12
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,693
-4.76%
|
$6,772
$4.22 P/Share
|
|
Jan 05
2021
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
2,740
-1.28%
|
$8,220
$3.91 P/Share
|
|
Jan 05
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
1,465
-3.55%
|
$4,395
$3.91 P/Share
|
|
Jan 05
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
862
-2.37%
|
$2,586
$3.9 P/Share
|
|
Jan 04
2021
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
3,515
+8.54%
|
$14,060
$4.02 P/Share
|
|
Jan 04
2021
|
James A Geraghty |
BUY
Grant, award, or other acquisition
|
Direct |
4,851
+4.43%
|
$19,404
$4.02 P/Share
|
|
Jan 04
2021
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
3,452
+8.31%
|
$13,808
$4.02 P/Share
|
|
Jan 04
2021
|
Carol Schafer |
BUY
Grant, award, or other acquisition
|
Direct |
3,620
+6.95%
|
$14,480
$4.02 P/Share
|